INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 145 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,845 | +959.7% | 531 | +532.1% | 0.00% | – |
Q2 2023 | $929 | -85.7% | 84 | -82.6% | 0.00% | – |
Q1 2023 | $6,487 | -53.7% | 483 | -51.2% | 0.00% | – |
Q3 2022 | $14,000 | +600.0% | 989 | +678.7% | 0.00% | – |
Q1 2022 | $2,000 | +100.0% | 127 | +126.8% | 0.00% | – |
Q4 2021 | $1,000 | -80.0% | 56 | -71.7% | 0.00% | – |
Q1 2021 | $5,000 | 0.0% | 198 | -7.5% | 0.00% | – |
Q4 2020 | $5,000 | +400.0% | 214 | +872.7% | 0.00% | – |
Q3 2020 | $1,000 | -75.0% | 22 | -75.0% | 0.00% | – |
Q2 2020 | $4,000 | 0.0% | 88 | +203.4% | 0.00% | – |
Q4 2019 | $4,000 | +100.0% | 29 | 0.0% | 0.00% | – |
Q3 2019 | $2,000 | 0.0% | 29 | 0.0% | 0.00% | – |
Q2 2019 | $2,000 | -33.3% | 29 | 0.0% | 0.00% | – |
Q1 2019 | $3,000 | -97.5% | 29 | -97.6% | 0.00% | – |
Q4 2018 | $121,000 | -17.1% | 1,201 | +3.9% | 0.00% | – |
Q3 2018 | $146,000 | -2.0% | 1,156 | -34.9% | 0.00% | – |
Q2 2018 | $149,000 | +38.0% | 1,775 | +1.4% | 0.00% | – |
Q1 2018 | $108,000 | +881.8% | 1,751 | +821.6% | 0.00% | – |
Q4 2017 | $11,000 | +175.0% | 190 | +156.8% | 0.00% | – |
Q3 2017 | $4,000 | -66.7% | 74 | -26.0% | 0.00% | – |
Q2 2017 | $12,000 | -90.8% | 100 | -91.3% | 0.00% | – |
Q1 2017 | $130,000 | -62.0% | 1,153 | -44.4% | 0.00% | -100.0% |
Q3 2016 | $342,000 | +245.5% | 2,075 | +198.1% | 0.00% | – |
Q2 2016 | $99,000 | +1137.5% | 696 | +2075.0% | 0.00% | – |
Q2 2014 | $8,000 | -98.3% | 32 | -97.8% | 0.00% | -100.0% |
Q1 2014 | $484,000 | +1692.6% | 1,469 | +267.2% | 0.00% | – |
Q4 2013 | $27,000 | -75.9% | 400 | -84.0% | 0.00% | -100.0% |
Q2 2013 | $112,000 | – | 2,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |